Amgen Inc. (NASDAQ:AMGN)

Paying user area

Try for free

Amgen Inc. pages available for free this week:

• Income Statement 
• Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
• Analysis of Profitability Ratios 
• Analysis of Long-term (Investment) Activity Ratios 
• Enterprise Value to EBITDA (EV/EBITDA) 
• Price to FCFE (P/FCFE) 
• Price to Operating Profit (P/OP) since 2005 
• Price to Book Value (P/BV) since 2005 
• Analysis of Revenues 
• Analysis of Debt 

The data is hidden behind: . Unhide it.

• Get full access to the entire website from $10.42/mo, or

• get 1-month access to Amgen Inc. for $24.99.

Get access

This is a one-time payment. There is no automatic renewal.

---

We accept:

Amgen Inc., common-size consolidated income statement (quarterly data)

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).